期刊
ASIAN JOURNAL OF PSYCHIATRY
卷 63, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.ajp.2021.102744
关键词
Antipsychotics; Antidepressants; Monopharmacy; Polypharmacy; EGUIDE
类别
资金
- Japan Agency for Medical Research and Development (AMED) [JP16dk0307060]
- AMED [JP19dk0307083]
- Health and Labor Sciences Research Grants [H29SeishinIppan001, 19GC1201]
- Japanese Society of Neuropsychopharmacology
- Japanese Society of Mood Disorders
- Japanese Society of Clinical Neuropsychopharmacology
The analysis of discharge prescription data for patients with schizophrenia and MDD revealed differences in prescription patterns for antipsychotics and hypnotics/anxiolytics among patients of different age groups, as well as the common practice of polypharmacy.
Background: Monopharmacy with antipsychotics and antidepressants is the first-line treatment for schizophrenia and major depressive disorder (MDD) in most clinical guidelines, while polypharmacy with psychotropic agents in the treatment of schizophrenia is common in clinical practice. There are no detailed data on the prescription patterns for inpatients with mental illness with reliable diagnoses made by treating psychiatrists. Methods: We gathered prescription data at discharge from 2177 patients with schizophrenia and 1238 patients with MDD from October 2016 to March 2018. Results: The patients with schizophrenia aged between 60 and 79 were prescribed lower doses of antipsychotics and hypnotics/anxiolytics than those aged between 40 and 59. There were significant differences between the prescription rate of antipsychotics in the patients with schizophrenia and that of antidepressants in the patients with MDD. The frequency of concomitant drugs such as anti-Parkinson drugs, anxiolytics/hypnotics and mood stabilizers in the subjects with schizophrenia prescribed antipsychotic polypharmacy was significantly higher than that with monotherapy. For the patients with schizophrenia, olanzapine, risperidone, aripiprazole, quetiapine, and blonanserin were the five most prescribed antipsychotics. For the patients with MDD, mirtazapine, duloxetine, escitalopram, trazodone and sertraline were the five most prescribed antidepressants. Conclusions: Our results showed the use of high doses of antipsychotics, high percentages of antipsychotic polypharmacy and concurrent use of hypnotics/anxiolytics in patients with schizophrenia. Notably, these data were collected before intensive instruction regarding the guidelines; therefore, we need to assess the change in the prescription pattern post guideline instruction.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据